Esomeprazole: all 260 studies that test it
Page 2 of 3. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in AdultsStatus unknownNCT03730766Phase 4
- Esomeprazole With Sildenafil Citrate in Women With Early-onset PreeclampsiaStatus unknownNCT03724838Not applicable
- Esomeprazole for the Prevention of PreeclampsiaStatus unknownNCT03717740Phase 3
- Metformin and Esomeprazole in Treatment of Early Onset PreeclampsiaStatus unknownNCT03717701Not applicable
- Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin AllergyCompletedNCT03708848Phase 4
- The Effect of Esomeprazole on Type 2 DiabetesCompletedNCT03598738Not applicable
- Genotypic Resistance Guided Therapy for Refractory H. Pylori InfectionStatus unknownNCT03555526Phase 4
- A Unique Regimen for Treatment of Helicobacter Pylori InfectionStatus unknownNCT03491995Phase 3
- Whether Proton Pump Inhibitors, Administered Prior to or After Surgery, Can Reduce the Incidence and/or Severity of Difficulty Swallowing Foods and/or Liquids,Following Anterior Cervical SurgeryWithdrawnNCT03488147Phase 2
- Esomeprazole to Reduce Organ Failure in SepsisCompletedNCT03452865Phase 3
- Safety Trial of Herbal Melanin in Gastritis PatientsStatus unknownNCT03428568Phase 2
- Tailored Therapy for Helicobacter Pylori Rescue TreatmentCompletedNCT03413020Phase 4
- Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole FormulationsStatus unknownNCT03372850Phase 1
- Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia PatientsCompletedNCT03333603Phase 4
- Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial)CompletedNCT03213639Phase 2/3
- Sequential Versus Quadruple Therapy in the Second-line TreatmentStatus unknownNCT03208426Phase 4
- A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.CompletedNCT03137134Phase 1
- Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and BCompletedNCT03128736Phase 4
- Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male VolunteersStatus unknownNCT03127046Phase 1
- 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori InfectionCompletedNCT02959255Phase 4
- Intragastric pH and Bismuth Effect for H. Pylori EradicationCompletedNCT02894892Not applicable
- The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESDCompletedNCT02730533Not applicable
- Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori InfectionCompletedNCT02711176Phase 4
- Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release CapsulesCompletedNCT02680132Phase 1
- BE of Torrent's Esomeprazole Mg DR CapsulesCompletedNCT02680119Phase 1
- Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERDCompletedNCT02670642Phase 3
- Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting ConditionsCompletedNCT02659683Phase 1
- Proton Pump Inhibitors Use in Patients With PsoriasisWithdrawnNCT02624544Phase 4
- High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori InfectionStatus unknownNCT02553083Phase 4
- Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With EsomeprazoleWithdrawnNCT02552641Phase 4
- Bioequivalence of Two Formulations of EsomeprazoleCompletedNCT02543606Phase 4
- Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar RemovalCompletedNCT02494856Phase 4
- PROGRESSive Withdrawal Esomeprazole and Acid-related SymptomsActive, not recruitingNCT02476097Phase 4
- Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk PatientsCompletedNCT02456012Phase 4
- The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot StudyCompletedNCT02359604Not applicable
- A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic PainCompletedNCT02197143Phase 4
- Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional DyspepsiaStatus unknownNCT02134405Phase 4
- A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of IsavuconazoleCompletedNCT02128893Phase 1
- Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective StudyCompletedNCT02081404Not applicable
- 15-day Sequential Therapy for Helicobacter Pylori Infection in KoreaCompletedNCT01887249Phase 4
- PPI for Prevention of Post-sphincterotomy BleedingCompletedNCT01873079Phase 3
- Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal RefluxCompletedNCT01854970Not applicable
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics and SafetyCompletedNCT01820143Phase 1
- Quadruple Versus Sequential Therapy for Helicobacter Pylori EradicationCompletedNCT01760824Not applicable
- The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic UlcersCompletedNCT01591083Phase 4
- The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated OphthalmopathyCompletedNCT01579539Phase 3
- Drug Drug Interaction Study Of Crizotinib With Esomeprazole.CompletedNCT01549574Phase 1
- Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male SubjectsCompletedNCT01494402Phase 1
- Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBICWithdrawnNCT01471925Phase 3
- Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult VolunteersCompletedNCT01358383Phase 1
- BRAVO Study for Functional DyspepsiaCompletedNCT01349413Phase 4
- Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori EradicationCompletedNCT01306786Not applicable
- A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic TherapyStatus unknownNCT01275937Phase 4
- An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of ClopidogrelCompletedNCT01210339Phase 1
- Study to Evaluate the Interaction Between Aspirin and NexiumCompletedNCT01199328Phase 1
- Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mgCompletedNCT01163630Phase 1
- Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of ClopidogrelCompletedNCT01147588Phase 1
- Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic TherapyCompletedNCT01142245Phase 3
- Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy VolunteersCompletedNCT01135472Phase 1
- Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.Status unknownNCT01129713Phase 1/2
- Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)WithdrawnNCT01123031Phase 4
- A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose AspirinCompletedNCT01094483Phase 1
- Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERDStatus unknownNCT01089959Phase 2/3
- Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving PerformanceCompletedNCT01079884Not applicable
- Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With AspirinCompletedNCT01062516Phase 4
- Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken SeparatelyTerminatedNCT01015729Phase 1
- The Effect of Esomeprazole and Fundoplication on AirwaysCompletedNCT00994708Phase 3
- Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn AloneCompletedNCT00992381Phase 1
- Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer DyspepsiaStatus unknownNCT00978159Phase 4
- Gastric Functions & Proton Pump Inhibitor( PPI) StudyCompletedNCT00951431Phase 4
- Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn ECompletedNCT00907400Phase 1
- Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer RebleedingWithdrawnNCT00881413Phase 4
- A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast CancerCompletedNCT00849329Phase 1
- Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCPCompletedNCT00786695Not applicable
- Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn ECompletedNCT00761501Phase 1
- Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected PatientsCompletedNCT00723502Phase 2
- Study Evaluating the Bioavailability of Naproxen 375 mg in Two FormulationsCompletedNCT00692055Phase 1
- Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free CombinationCompletedNCT00688428Phase 1
- Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)CompletedNCT00687245Phase 1
- Drug Interaction Study Between AZD3355 and NexiumCompletedNCT00684190Phase 1
- Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart DiseaseCompletedNCT00683111Phase 4
- Study Evaluating the Effect of Food on the Bioavailability of PN400 ComponentsCompletedNCT00676442Phase 1
- Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese MalesCompletedNCT00676117Phase 1
- Study Evaluating the Bioavailability of Naproxen 500 mg in Three FormulationsCompletedNCT00665743Phase 1
- Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been HealedCompletedNCT00644735Phase 4
- A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive EsophagitisCompletedNCT00641602Phase 4
- Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced GastropathyCompletedNCT00641004Phase 4
- Barrett's Esophagus - 315 - 3 Way Cross OverCompletedNCT00637988Phase 4
- Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)CompletedNCT00637845Phase 4
- Barrett's Esophagus - 315 - 3 Way Cross-OverCompletedNCT00637559Phase 4
- Open, Randomized, Two Way Crossover 40mg, Orally and IntravenouslyCompletedNCT00635414Phase 4
- A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is ContinuedCompletedNCT00633672Phase 3
- A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US OnlyCompletedNCT00633412Phase 3
- Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care UnitCompletedNCT00633035Phase 4
- Ulcer Prevention IICompletedNCT00629928Phase 3
- An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00629564Phase 4
- Prevention of Gastric UlcersCompletedNCT00629512Phase 3
- Adult Asthmatics and Acid RefluxCompletedNCT00628953Phase 2
- Chronic Posterior Laryngitis With Suspected Laryngopharyngeal RefluxCompletedNCT00628667Phase 4
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)CompletedNCT00628342Phase 4